Moments ago, Joseph R. Biden, Jr. was sworn in as the 46th President of the United States, and his administration is expected to bring some immediate policy changes to FDA.
The primary focus of the Biden Administration will be the COVID-19 pandemic. President Biden has already appointed former FDA Commissioner David Kessler as Chief Science Officer to coordinate COVID vaccine development and approval.
The President is expected to invoke the Defense Production Act to compel private industry to produce large quantities of tests, personal protective equipment, vaccines, and COVID treatments.
The President is also expected to rejoin global health partnerships, such as the World Health Organization, to support global vaccine development, vaccine production, and vaccine distribution.
Lastly, the President is expected to support ongoing deregulation of telemedicine, an area that is largely regulated by the states and that has experienced an exponential growth in demand during the coronavirus pandemic.
Stay tuned to The Law of Life Sciences for updates on the Biden Administration’s changes at FDA.
thelawoflifesciences.com 